Arvinas, Inc. (ARVN) — 10-Q Filings

10-Q Filings (6)

• Arvinas Narrows Losses, Boosts 9-Month Revenue on R&D Efficiency — Nov 5, 2025 Risk: medium
  ARVINAS, INC. reported a significant decrease in revenue for the three months ended September 30, 2025, falling to $41.9 million from $102.4 million in the prio
• Arvinas Q2 Loss Widens Amid R&D Push — Aug 6, 2025 Risk: high
  ARVINAS, INC. reported a net loss of $120.4 million for the three months ended June 30, 2025, a significant increase from the $105.2 million net loss in the pri
• Arvinas, Inc. Files Q1 2025 10-Q Financial Report — May 1, 2025 Risk: medium
  Arvinas, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial results for the first quarter of 2025, detailing its asset
• Arvinas Q3 2024 10-Q Filed — Oct 30, 2024 Risk: medium
  Arvinas, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results for the third quarter of 2024, detailing reven
• Arvinas, Inc. Files Q2 2024 Quarterly Report — Jul 30, 2024 Risk: low
  Arvinas, Inc. filed its quarterly report for the period ended June 30, 2024. The company, incorporated in Delaware with its principal executive offices in New H
• Arvinas, Inc. Files 10-Q for Period Ending March 31, 2024 — May 7, 2024 Risk: low
  ARVINAS, INC. (ARVN) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Arvinas, Inc. filed a 10-Q report for the period ending March 31, 2024. The fi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX